soul study semaglutide cardiovascular outcomes news today 2025 trial oral results in High- Risk Type 2 Diabetes: Benefit Confirmed in the SOUL Trial Shows Oral Semaglutide – Semaglutide 2.4 mg delivered a – Forecasting Trial Milestones: A Predictive
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8

















01163-7/asset/574129d4-809d-4296-9b7e-10d493ffcfad/main.assets/gr1_lrg.jpg)




